Icotrokinra vs Orforglipron
Overview
Icotrokinra is primarily a immune support peptide, while Orforglipron is used for weight management & metabolic.
This page compares Icotrokinra and Orforglipron across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | Orforglipron | |
|---|---|---|
| Category | Immune Support | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | — | Clinical trials |
| Frequency | — | daily |
| Reported benefits | — | Oral administration convenience, weight loss, glucose control |
| Reported side effects | — | Under investigation |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while Orforglipron falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. Orforglipron: FDA-approved.
Dosing. Typical dosing for Icotrokinra is not catalogued. Orforglipron is typically dosed at Clinical trials (daily).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and Orforglipron has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and Orforglipron?
- Icotrokinra is primarily a immune support peptide, while Orforglipron is used for weight management & metabolic. Icotrokinra is FDA-approved for one or more indications, whereas Orforglipron is FDA-approved for one or more indications.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is Orforglipron used for?
- Oral GLP-1.
- Can you take Icotrokinra and Orforglipron together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and Orforglipron has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or Orforglipron FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. Orforglipron is FDA-approved for one or more indications.
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- Orforglipron — full monograph: mechanism, research, dosing & references